English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer

Schöttle, J., Chatterjee, S., Volz, C., Siobal, M., Florin, A., Rokitta, D., et al. (2015). Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget, 6(36), 38458-38468. doi:10.18632/oncotarget.6276.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Schöttle, Jakob1, Author           
Chatterjee, Sampurna2, Author           
Volz, Caroline, Author
Siobal, Maike3, Author           
Florin, Alexandra, Author
Rokitta, Dennis, Author
Hinze, Yvonne4, Author           
Dietlein, Felix3, Author           
Plenker, Dennis, Author
König, Katharina, Author
Albus, Kerstin, Author
Heuckmann, Johannes M.3, Author           
Rauh, Daniel, Author
Franz, Thomas, Author
Neumaier, Bernd5, Author           
Fuhr, Uwe, Author
Heukamp, Lukas C., Author
Ullrich, Roland T.1, Author           
Affiliations:
1Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663              
2In-vivo-NMR, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149666              
3Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              
4Bio-MS, Core Facilities, Max Planck Institute for Biology of Ageing, Max Planck Society, ou_1942305              
5Radiochemistry, Scientific Services and Development, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149672              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2015
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.18632/oncotarget.6276
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Oncotarget
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 6 (36) Sequence Number: - Start / End Page: 38458 - 38468 Identifier: ISSN: 19492553